Every Form 4 that RESEARCH SOLUTIONS INC (RSSS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RSSS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RSSS filings page.
Research Solutions, Inc. reports that Chief Revenue Officer Sefton Cohen disposed of common stock through a forfeiture of 284000.0000 unvested restricted shares back to the company on 2026-07-31. According to the award terms, the shares were forfeited for no consideration upon termination of employment, leaving 75933.0000 shares held directly.
Cohen Sefton reported acquisition or exercise transactions in this Form 4 filing.
Research Solutions, Inc. Chief Revenue Officer Cohen Sefton received a grant of 80,000 shares of restricted common stock valued at $2.29 per share as equity compensation. One‑third of these restricted stock awards vest on March 18, 2027, with the remainder vesting quarterly beginning March 31, 2027. Following this award, Sefton directly holds 359,933 shares of common stock.
A director of Research Solutions, Inc. reported receiving an option to purchase 50,000 shares of the company’s common stock. The stock option was granted on 11/12/2025 with an exercise price of $3.07 per share and an expiration date of 11/11/2035. The option was reported as directly owned and carried a price of $0 at grant, indicating it was an award rather than a market purchase.
According to the vesting terms, one-third of the options vest on November 12, 2026, and one-twelfth of the options vest on the last day of each quarter beginning December 31, 2026 until fully vested. This creates a multi‑year vesting schedule that ties the director’s potential ownership to ongoing service and future company performance.
Research Solutions, Inc. reported that one of its directors exercised stock options to acquire 75,000 shares of common stock on 11/12/2025 at an exercise price of $0.7 per share. Following this transaction, the director directly beneficially owns 484,608 shares of the company’s common stock.
On the same date, the director was granted a new option to purchase 50,000 shares of common stock at an exercise price of $3.07 per share, expiring on 11/11/2035. According to the vesting schedule, one third of these options vest on November 12, 2026 and one twelfth vest on the last day of each quarter beginning December 31, 2026 until fully vested, while the previously held option for 75,000 shares at $0.7 was fully exercised and now shows 0 remaining.
Research Solutions, Inc. (RSSS) director Form 4 reports an option exercise and share acquisition. On 11/17/2025, the reporting director exercised an option to purchase 150,000 shares of common stock at an exercise price of $0.70 per share, coded as transaction type "M" (option exercise). After this transaction, the director beneficially owned 318,500 shares of common stock directly and 75,000 shares indirectly through an IRA. A corresponding entry in the derivative table shows the option to purchase 150,000 shares at $0.70, originally exercisable on 12/04/2015 and expiring on 12/03/2025, with zero derivative securities remaining following this exercise.
Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant for 60,000 shares of common stock on 11/12/2025 at an exercise price of $3.07 per share. These stock options expire on 11/11/2035, giving the holder a long window to buy shares at that price if they choose.
The options vest over time. One-third of the grant vests on 11/12/2026, and the remaining two-thirds vest in equal installments on the last day of each quarter beginning 12/31/2026 until fully vested. Following this transaction, the reporting person directly holds 60,000 derivative securities (stock options) tied to Research Solutions common stock.
Research Solutions, Inc. (RSSS) reported a new equity award to one of its directors on a Form 4. On November 12, 2025, the director was granted an option to purchase 50,000 shares of common stock at an exercise price of $3.07 per share, expiring on November 11, 2035. The option was acquired as a direct holding with no cash price for the derivative itself. The vesting schedule provides that one-third of the options vest on November 12, 2026, and one-twelfth vest on the last day of each quarter beginning December 31, 2026 until fully vested.
Research Solutions, Inc. (RSSS) reported that one of its directors received an option grant to purchase 50,000 shares of common stock on 11/12/2025. The stock options have an exercise price of $3.07 per share and expire on 11/11/2035. According to the vesting schedule, one-third of the options vest on November 12, 2026, with the remaining options vesting in equal quarterly installments on the last day of each quarter beginning December 31, 2026 until fully vested. The options are held as direct ownership by the reporting person.
William Nurthen, Chief Financial Officer and Secretary of Research Solutions, Inc. (RSSS), reported a transaction dated 09/19/2025 in which he surrendered 2,225 shares of the company’s common stock to the issuer to cover taxes on vested restricted stock at an effective price of $3.66 per share. After the surrender, he beneficially owned 378,382 shares. The filing is signed by Mr. Nurthen on 09/26/2025. The explanation states the share surrender was approved by the Compensation Committee.
Research Solutions, Inc. insider share surrender to cover taxes
CEO & President Olivier Roy W reported a Form 4 disclosing a non-derivative transaction on 09/19/2025 in which 1,428 shares of Research Solutions, Inc. (RSSS) were disposed of at a price of $3.66 per share. The filing states these shares were surrendered to the company to cover taxes on vested restricted stock as approved by the Compensation Committee. After the transaction the reporting person beneficially owned 606,825 shares. The transaction appears to be a routine tax-withholding action tied to equity compensation rather than an open-market sale.